Community news

To improve profitability and thereby increasing the amount our public foundation owner can donate to academic research each year, and to maintain an appropriate cost level for our members, Medicon Village Fastighet has, over the past few years, worked intensively to strengthen its procurement function. By optimising purchasing, negotiating agreements …

After three intensive days at Vitalis 2026, the Medicon Village team returned with new insights, strengthened relationships and valuable discussions on the future of digital health and healthcare innovation. Held annually at Svenska Mässan, Vitalis has established itself as one of the Nordic region’s leading meeting places for health, healthcare …

This 1-day course on Cybersecurity standards for medical devices is designed to help professionals gain an understanding of the current standards within cybersecurity for medical devices and an overview of the cybersecurity requirements in the IVDR and MDR. Next session: Online, 27 May 2026 (held in English) Time: 08:30 – …

Medicon Village has now launched the Skåne Life Science Barometer 2026, our annual report taking the pulse of the life science sector in Skåne. The report provides a data-driven overview of the regional ecosystem, combining company statistics with insights from life science executives and interviews with companies representing Skåne’s key …

While MDR has placed high demands on medical device manufacturers, a new reality is emerging in healthcare. AI‑based triage tools, prioritization systems, and digital clinical assistants are increasingly shaping clinical decisions – yet are often introduced as “IT support,” without equivalent regulatory scrutiny. When AI‑driven tools influence patient flows, assessments, …

Aventera Antibodies, a portfolio company of SmiLe Venture Hub, has successfully raised SEK 14.5 million in a funding round from Swedish and international investors. The funding will support the preclinical development of the company’s lead drug candidate targeting life-threatening streptococcal infections, with the ambition to enter clinical trials in 2028.

The cancer diagnostics company Capillon Analytics AB (part of Kreftect) has achieved CLIA registration under U.S. regulatory requirements, and can thereby analyze patients’ hair samples from clinical studies in the United States. The registration marks an important step toward establishing the company’s prostate cancer detection test on the U.S. market.

Insights on medical device training, regulatory compliance and the future of learning in MedTech.  With more than 20 years of experience from the Medical Device and Pharmaceutical industries, Åse Ek has built her career at the intersection of product development, quality and regulatory affairs. Today, she leads the Training & Education area at GBA …

A new opinion article published in Dagens Medicin highlights the urgent need to accelerate the adoption of innovations within Sweden’s healthcare system. The publication follows a fully booked seminar held at the Swedish Parliament, hosted by Mats Persson (L) and Ewa Pihl-Krabbe …

Together with Intertek Academy, we offer a 2-day course in Stockholm, Sweden, covering Medical device software process design based on IEC 62304. This course is designed for professionals developing or managing medical devices containing software or software as a medical device (SaMD).   What you’ll learn: •  Current software practices •  Designing high …

Earlier this week, Medicon Village’s Innovation Manager, Francesco Bez, took part as a judge in the National ATMP Research School pitch competition, held at Grand Hotel in Lund. He was joined by representatives from Lund University, LU Innovation and SmiLe Venture Hub. The competition was organised by the National ATMP …

We are thrilled to announce that the full agenda for Global Forum 2026 is now officially confirmed. This year, we’ve curated a high-impact program designed to bridge the gap between breakthrough science and the capital needed to scale it. What’s on the menu? This year’s agenda is packed with sessions …